| S1601 |
Reserpine
|
Reserpine is an inhibitor of multidrug efflux pumps, used as an antipsychotic and antihypertensive drug. This compound is an inhibitor of the vesicular monoamine transporter 2 (VMAT2).It can be used to induce animal models of Gastric and Intestinal Ulcers.
|
-
Mol Psychiatry, 2025, 10.1038/s41380-025-03374-6
-
J Immunother Cancer, 2024, 12(11)e009805
-
Int J Mol Sci, 2022, 23(9)4597
|
|
| S9500 |
Valbenazine tosylate
|
Valbenazine tosylate (NBI-98854) is the tosylate salt of valbenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor with a Ki value of 150 nM while displaying no significant binding to VAMT1(Ki<10 μM).
|
-
Cell Rep Med, 2023, 4(10):101208
-
Cell Rep Med, 2023, 4(10):101208
|
|
| E6053New |
tetrabenazine
|
Tetrabenazine (Ro 1-9569) is a non-competitive inhibitor of the vesicular monoamine transporter (VMAT), with a higher selectivity for VMAT2 over VMAT1. It exhibits an IC50 of 0.3 µM for VMAT2 and 3 µM for VMAT1, and a Kd of 60 nM for VMAT2 and 9.38 nM for VMAT1. It treats Huntington’s chorea by reducing excessive dopaminergic activity and impairing monoamine storage in synaptic vesicles.
|
-
Mol Psychiatry, 2025, 10.1038/s41380-025-03374-6
|
|
| E6074New |
Reserpine hydrochloride
|
Reserpine hydrochloride (Serpivite hydrochloride) is a potent inhibitor of the vesicular monoamine transporter 2 (VMAT2) and depletes monoamines from nerve terminals. It exhibits the potential to produce a pharmacological model of depression in animals.
|
|
|
| E4844 |
Valbenazine
|
Valbenazine(Ingrezza, Mt-5199, NBI-98854, VBZ) is a potent inhibitor of vesicular monoamine transporter 2 (VMAT2) with a Ki of 110–190 nM. It is used to treat tardive dyskinesia and chorea associated with Huntington's disease.
|
|
|